基于美国FAERS的新型口服抗凝药物致女性生殖系统异常出血风险的数据分析(4)
[ 8 ] TOWFIGHI A，ZHENG L，OVBIAGELE B. Sex-specific trends in midlife coronary heart disease risk and prevalence[J]. Arch Intern Med，2009，169(19)：1762-1766.[ 9 ] FDA. FDA drug safety communication：safety review of post-market reports of serious bleeding events with anticoagulant Pradaxa(dabigatran etexilate mesylate)[EB/OL].[2020-03-01]. https：//www.fda.gov/drugs/drug-safety-and- availability.
[10] 封学伟 ......
您现在查看是摘要页，全文长 2545 字符。